- Home
- CREG vs EVAX Comparison
CREG vs EVAX Comparison
Compare CREG & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREG
- EVAX
- Stock Information
- Founded
- CREG N/A
- EVAX 2008
- Country
- CREG China
- EVAX Denmark
- Employees
- CREG N/A
- EVAX N/A
- Industry
- CREG Power Generation
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CREG Utilities
- EVAX Health Care
- Exchange
- CREG Nasdaq
- EVAX Nasdaq
- Market Cap
- CREG 16.6M
- EVAX 16.3M
- IPO Year
- CREG N/A
- EVAX 2021
- Fundamental
- Price
- CREG $0.73
- EVAX $1.64
- Analyst Decision
- CREG
- EVAX Strong Buy
- Analyst Count
- CREG 0
- EVAX 2
- Target Price
- CREG N/A
- EVAX $10.00
- AVG Volume (30 Days)
- CREG 56.9K
- EVAX 64.1K
- Earning Date
- CREG 05-27-2025
- EVAX 05-27-2025
- Dividend Yield
- CREG N/A
- EVAX N/A
- EPS Growth
- CREG N/A
- EVAX N/A
- EPS
- CREG N/A
- EVAX N/A
- Revenue
- CREG N/A
- EVAX $3,344,000.00
- Revenue This Year
- CREG N/A
- EVAX $102.45
- Revenue Next Year
- CREG N/A
- EVAX $100.30
- P/E Ratio
- CREG N/A
- EVAX N/A
- Revenue Growth
- CREG N/A
- EVAX 4480.82
- 52 Week Low
- CREG $0.49
- EVAX $1.20
- 52 Week High
- CREG $1.19
- EVAX $20.81
- Technical
- Relative Strength Index (RSI)
- CREG 58.80
- EVAX 55.67
- Support Level
- CREG $0.58
- EVAX $1.42
- Resistance Level
- CREG $0.90
- EVAX $1.62
- Average True Range (ATR)
- CREG 0.07
- EVAX 0.11
- MACD
- CREG 0.01
- EVAX 0.03
- Stochastic Oscillator
- CREG 48.48
- EVAX 62.86
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.